Figures & data
Table 1. Baseline demographics and clinical characteristics of all NHRs with a diagnosis of type 2 diabetes (diabetes) in the MDS and the subset with prescription claims data.
Figure 1. Treatment received by NHRs with a diagnosis of type 2 diabetes mellitus: (a) oral antidiabetic therapy; and (b) injectable therapies are shown.
![Figure 1. Treatment received by NHRs with a diagnosis of type 2 diabetes mellitus: (a) oral antidiabetic therapy; and (b) injectable therapies are shown.](/cms/asset/1b41ad6f-7fe6-4a06-bddf-7f6cbdcdae90/ipgm_a_1035621_f0001_ob.jpg)
Figure 2. Treatment persistence among nursing home residents with a diagnosis of type 2 diabetes mellitus is shown.
![Figure 2. Treatment persistence among nursing home residents with a diagnosis of type 2 diabetes mellitus is shown.](/cms/asset/4ab6eb0d-d998-4497-8637-7faff917e332/ipgm_a_1035621_f0002_ob.jpg)
Table 2. Concomitant prescription medication utilization in NHRs with a diagnosis of type 2 diabetes.
Table 3. Baseline demographics and clinical characteristics of NHRs with a diagnosis of type 2 diabetes who received antidiabetic medications (20% of NHRs had no claims for antidiabetic medications during the study period), by treatment group.